Abstract
The aim of study was to develop self-nanoemulsifying pellets (SNEP) for oral delivery of poorly water soluble drug, repaglinide (RPG). Solubility of RPG in oily phases and surfactants was determined to identify components of self-nanoemulsifying drug delivery system (SNEDDS). The surfactants and cosurfactants were screened for their ability to emulsify oily phase. Ternary phase diagrams were constructed to identify nanoemulsification area for the selected systems. SNEDDS formulations with globule size less than 100 nm were evaluated for in vivo anti-hyperglycemic activity in neonatal streptozotocin rat model. A significant reduction in glucose levels was produced by optimized SNEDDS formulation in comparison to the control group. The optimized SNEDDS formulations were pelletized via extrusion/spheronization technique using microcrystalline cellulose and lactose. SNEP were characterized by X-ray powder diffraction and scanning electron microscopy. X-ray diffraction study indicated loss of crystallinity of RPG in SNEP. The SNEP exhibited good flow properties, mechanical strength and formed nanoemulsion with globule size less than 200 nm. SNEP showed in vitro release of more than 80% RPG in 10 min which was significantly higher than RPG containing reference pellets. In conclusion, our studies illustrated that RPG, a poorly water soluble drug can be successfully formulated into SNEP which can serve as a promising system for the delivery of poorly water soluble drugs.
Similar content being viewed by others
References
Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 1997;25:103–28.
Culy C, Jarvis B. Repaglinide, a review of its therapeutic use in type 2 diabetes mellitus. Drugs. 2001;61:1625–60.
Malaisse W. Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies. Eur J Clin Invest. 1999;29:21–9.
Mandic Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal. 2006;41(3):866–71.
Marbury TC, Ruckle JL, Hatorp V, Andersen MP, Nielsen KK, Huang WC, et al. Pharmacokinetics of repaglinide in subjects with renal impairment. Clin Pharmacol Ther. 2000;67:7–15.
Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Hardman JG, Limbrid LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. USA: McGraw-Hill; 2001. p. 1704–5.
Sinswat P, Matteucci ME, Johnston KP, Williams III RO. Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation. J Biomed Nanotechnol. 2007;3:18–27.
Desai NS, Bramhane DM, Nagarsenker MS. Repaglinide–cyclodextrin complexes: preparation, characterization and in vivo evaluation of antihyperglycemic activity. J Incl Phenom Macrocycl Chem. 2011;70(1–2):217–25.
Zawar LR, Bari SB. Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion. Chem Pharm Bull. 2012;60(4):482–7.
Kavitha R, Sathali AAH. Enhancement of solubility of repaglinide by solid dispersion technique. Int J Chem Sci. 2012;10(1):377–90.
Patel M, Pandya N, Bhaskar VH. Preparation, characterization and in vitro evaluation of repaglinide binary solid dispersions with hydrophilic polymers. Int J Drug Dev & Res. 2011;3(2):107–17.
Seedher N, Kanojia M. Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note. AAPS PharmSciTech. 2008;9(2):431–6.
Purvis T, Mattucci ME, Todd MC, Johnston KP, Williams III RO. Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS PharmSciTech. 2007;8(3):E52–60.
Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–82.
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.
Wei W, Yang W, Li Q. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63:288–94.
Date A, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine. 2010;5(10):1595–616.
Chang RK, Raghavan KS, Hussain MA. A study on gelatin capsule brittleness: moisture transfer between the capsule shell and its content. J Pharm Sci. 1998;87:556–8.
Mei X, Etzler FM, Wang Z. Use of texture analyzer to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006;324:128–35.
Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech. 2009;10:183–92.
Dixit RP, Nagarsenker MS. Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm. 2008;34:1285–96.
Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 2009;72:539–45.
Tuleu C, Newton JM, Rose J, Euler D, Saklatvala R, Clarke A, et al. Comparative bioavailability study in dogs of a self emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004;93:1495–502.
Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-glycerides by extrusion/spheronization. Eur J Pharm Sci. 2007;30:333–42.
Xiongwei H, Chen L, Dingxiong C, Jing Z, Zhihong L, Wei W, et al. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm. 2012;438:123–33.
Abdalla A, Mäder K. Preparation and characterization of a self emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66:220–6.
Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166–72.
Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625–37.
Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60:673–91.
Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179–88.
Newton M, Petersson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci. 2001;90:987–95.
Shah NH, Phuapradit W, Zhang Y, Ahmed H, Malick AW. Lipid-Based Isotropic Solutions: Design Considerations. In: Hauss DJ, editor. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs. Informa Healthcare USA, Inc; 2007. p. 129–148.
Acknowledgments
The authors are thankful to USV India Pvt. Limited, India for providing gift sample of repaglinide. We are thankful to Colorcon Asia Pvt. Ltd., India; Gattefosse India Pvt Ltd., India; BASF India Ltd., India; Karlshamns AB., Sweden; S. Zaveri & Co., India; for providing gift samples of oils and surfactants. The authors are also thankful to Associated Capsules, India, for gift sample of hard gelatin capsules. The authors wish to thank Mr. Nilesh Kulkarni, Tata Institute of Fundamental Research (TIFR), Mumbai, India for carrying out X-ray diffraction studies. The authors are thankful to the Department of Biotechnology (DBT), New Delhi, for providing fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Desai, N.S., Nagarsenker, M.S. Design and Evaluation of Self-Nanoemulsifying Pellets of Repaglinide. AAPS PharmSciTech 14, 994–1003 (2013). https://doi.org/10.1208/s12249-013-9990-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-013-9990-9